| Dr Andrew Rollin Davis, MD | |
|
5215 Monticello Ave Ste A, Williamsburg, VA 23188-8232 | |
| (757) 229-4000 | |
| Not Available |
| Full Name | Dr Andrew Rollin Davis |
|---|---|
| Gender | Male |
| Speciality | Ophthalmology |
| Experience | 9 Years |
| Location | 5215 Monticello Ave Ste A, Williamsburg, Virginia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1700273539 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207W00000X | Ophthalmology | 0116029599 (Virginia) | Secondary |
| 207W00000X | Ophthalmology | 0101273193 (Virginia) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| David M Harman Md Llc | 6305828062 | 45 |
News Archive
Healthways, Inc. today announced the acquisition of HealthHonors, a market-leading behavioral economics company that specializes in behavior change science and optimized use of incentives, in a cash for stock transaction.
Research presented at the Society of Nuclear Medicine and Molecular Imaging's 2019 Annual Meeting draws a strong link between severe obstructive sleep apnea and impaired coronary flow reserve, which is an early sign of the heart disease atherosclerosis.
This study demonstrates that emotional and social self-efficacy beliefs may contribute on strengthening major expressions of positive orientation. The more people draw, from experience, their beliefs to be able to properly handle their emotions and their relations with others, the more they can preserve and enhance a positive evaluation of self, life and the future.
Stroke injures the brain, but a new University of South Florida study indicates an abdominal organ that plays a vital role in immune function, the spleen, may be a target for treating stroke-induced chronic inflammation leading to further brain cell death.
Bausch + Lomb, the global eye health company, today announced that the U.S. Food and Drug Administration has approved the company's New Drug Application for PROLENSA (bromfenac ophthalmic solution) 0.07 percent prescription eye drop, an innovative once-daily nonsteroidal anti-inflammatory drug for the treatment of postoperative inflammation and reduction of ocular pain in patients who have undergone cataract surgery.
› Verified 5 days ago
| Entity Name | David M Harman Md Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1306950431 PECOS PAC ID: 6305828062 Enrollment ID: O20040605000053 |
News Archive
Healthways, Inc. today announced the acquisition of HealthHonors, a market-leading behavioral economics company that specializes in behavior change science and optimized use of incentives, in a cash for stock transaction.
Research presented at the Society of Nuclear Medicine and Molecular Imaging's 2019 Annual Meeting draws a strong link between severe obstructive sleep apnea and impaired coronary flow reserve, which is an early sign of the heart disease atherosclerosis.
This study demonstrates that emotional and social self-efficacy beliefs may contribute on strengthening major expressions of positive orientation. The more people draw, from experience, their beliefs to be able to properly handle their emotions and their relations with others, the more they can preserve and enhance a positive evaluation of self, life and the future.
Stroke injures the brain, but a new University of South Florida study indicates an abdominal organ that plays a vital role in immune function, the spleen, may be a target for treating stroke-induced chronic inflammation leading to further brain cell death.
Bausch + Lomb, the global eye health company, today announced that the U.S. Food and Drug Administration has approved the company's New Drug Application for PROLENSA (bromfenac ophthalmic solution) 0.07 percent prescription eye drop, an innovative once-daily nonsteroidal anti-inflammatory drug for the treatment of postoperative inflammation and reduction of ocular pain in patients who have undergone cataract surgery.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Andrew Rollin Davis, MD Po Box 45923, Baltimore, MD 21297-5923 Ph: (877) 969-0392 | Dr Andrew Rollin Davis, MD 5215 Monticello Ave Ste A, Williamsburg, VA 23188-8232 Ph: (757) 229-4000 |
News Archive
Healthways, Inc. today announced the acquisition of HealthHonors, a market-leading behavioral economics company that specializes in behavior change science and optimized use of incentives, in a cash for stock transaction.
Research presented at the Society of Nuclear Medicine and Molecular Imaging's 2019 Annual Meeting draws a strong link between severe obstructive sleep apnea and impaired coronary flow reserve, which is an early sign of the heart disease atherosclerosis.
This study demonstrates that emotional and social self-efficacy beliefs may contribute on strengthening major expressions of positive orientation. The more people draw, from experience, their beliefs to be able to properly handle their emotions and their relations with others, the more they can preserve and enhance a positive evaluation of self, life and the future.
Stroke injures the brain, but a new University of South Florida study indicates an abdominal organ that plays a vital role in immune function, the spleen, may be a target for treating stroke-induced chronic inflammation leading to further brain cell death.
Bausch + Lomb, the global eye health company, today announced that the U.S. Food and Drug Administration has approved the company's New Drug Application for PROLENSA (bromfenac ophthalmic solution) 0.07 percent prescription eye drop, an innovative once-daily nonsteroidal anti-inflammatory drug for the treatment of postoperative inflammation and reduction of ocular pain in patients who have undergone cataract surgery.
› Verified 5 days ago
Leana S. Long, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 120 Kings Way, Suite 1300, Williamsburg, VA 23185 Phone: 757-345-1001 Fax: 757-345-3102 | |
Robert Douglas Cullom, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 120 Kings Way, Suite 1300, Williamsburg, VA 23185 Phone: 757-345-3001 Fax: 757-345-3102 | |
Dr. Anthony W. Farah, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 120 Kings Way, Suite 1300, Williamsburg, VA 23185 Phone: 757-345-3001 Fax: 757-345-3102 | |
Mr. Glenn C Campbell, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 5215 Monticello Ave, Williamsburg, VA 23188 Phone: 757-229-4000 | |
Dr. Franklin Lawrence Freda, M.D. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 204 Zelkova Rd, Williamsburg, VA 23185 Phone: 757-645-3394 | |
Dr. John R. Nordlund, M.D., PHD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 5215 Monticello Ave Ste A, Williamsburg, VA 23188 Phone: 757-229-4000 |